0
Article |

Malignant Melanoma vs Benign Tumors in the Young-Reply

Peter Berg, MD; Bernt Lindelöf, MD, PhD
[+] Author Affiliations

Department of Dermatology Danderyd Hospital S-182 88 Danderyd Sweden


Arch Dermatol. 1997;133(11):1460-1460. doi:10.1001/archderm.1997.03890470140027
Text Size: A A A
Published online

Malignant melanoma is considered a difficult diagnosis both clinically and histologically. Therefore, it is reasonable to presume that both overdiagnosis and underdiagnosis occur to a certain extent.

In our article,1 we omitted this subject because we are not pathologists and all the patients with melanoma registered in the Swedish Cancer Registry have been treated as patients with melanoma; thus, the lesions were removed with proper margins. Furthermore, the patients are informed that they have malignant melanoma.

With reference to the letter by Rosdahl and coworkers, we would like to point out that it is, of course, much easier to label the diagnosis as other than melanoma in a secondary situation when one has a long observation period behind and when the lesion is primarily removed. The pathologists in the primary situation have a much more difficult situation, and overdiagnosis can occur and might even be desirable to a certain

REFERENCES

Berg P, Lindelöf B.  Differences in malignant melanoma between children and adolescents: a 35-year epidemiological study . Arch Dermatol. 1997;;133:295-297.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Berg P, Lindelöf B.  Differences in malignant melanoma between children and adolescents: a 35-year epidemiological study . Arch Dermatol. 1997;;133:295-297.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.